{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:14:20Z","timestamp":1788542060331,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.semarthrit.2015.11.010","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T08:01:13Z","timestamp":1449129673000},"page":"S3-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"special_numbering":"S","title":["A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis\u2014From evidence-based medicine to the real-life setting"],"prefix":"10.1016","volume":"45","author":[{"given":"Olivier","family":"Bruy\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Maheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Rannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Luisa Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy D.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Martel-Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.11.010_bib1","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JOM.0b013e3181715111","article-title":"Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States","volume":"50","author":"White","year":"2008","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"44","author":"Bruyere","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib9","unstructured":"National Clinical Guideline Centre. Osteoarthritis care and management in adults: methods, evidence and recommendations. London, UK: National Institute for Health and Care Excellence; February 2014. Report No.: CG177."},{"issue":"4 Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib10","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.semarthrit.2015.11.011","article-title":"Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Bruyere","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4 Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib11","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","article-title":"Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Rannou","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4 Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib12","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.semarthrit.2015.11.009","article-title":"Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Pelletier","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4 Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.semarthrit.2015.11.008","article-title":"Efficacy and safety of hyaluronic acid in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Maheu","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib15","unstructured":"FDA. Drug Safety Communication 13 January 2011: Prescription Acetaminophen Products to be Limited to 325mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure. \u3008http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm239821.htm\u3009; 2011 [accessed 01.06.15]"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","article-title":"Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada","volume":"103","author":"Rahme","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","article-title":"Lifetime nonnarcotic analgesic use and decline in renal function in women","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib18","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/archinte.162.19.2204","article-title":"Frequency of analgesic use and risk of hypertension in younger women","volume":"162","author":"Curhan","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.167.4.394","article-title":"Frequency of analgesic use and risk of hypertension among men","volume":"167","author":"Forman","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1759720X09359104","article-title":"Effects of diacerein at the molecular level in the osteoarthritis disease process","volume":"2","author":"Martel-Pelletier","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib21","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T","article-title":"Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1529-0131(199801)41:1<81::AID-ART11>3.0.CO;2-9","volume":"41","author":"Maheu","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib23","first-page":"CD002946","article-title":"Glucosamine therapy for treating osteoarthritis","volume":"2","author":"Towheed","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.22852","article-title":"The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest","volume":"56","author":"Reginster","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib25","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/acr.22376","article-title":"Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials","volume":"66","author":"Eriksen","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib27","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Pavelka","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib28","unstructured":"De Wan M, Volpi G inventors; Rottapharm, assignee. Method of preparing mixed glucosamine salts. USA patent 5,847,107. 1998."},{"key":"10.1016\/j.semarthrit.2015.11.010_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.22371","article-title":"Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator","volume":"56","author":"Herrero-Beaumont","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","article-title":"Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials","volume":"329","author":"Bjordal","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1185\/03007995.2013.792793","article-title":"How to define responders in osteoarthritis","volume":"29","author":"Cooper","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.joca.2007.06.011","article-title":"Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials","volume":"16","author":"Bruyere","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"issue":"4 Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib33","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.semarthrit.2015.10.009","article-title":"Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study","volume":"45","author":"Rovati","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1742-1241.2010.02362.x","article-title":"Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol","volume":"64","author":"Scholtissen","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/ecp.09.17","article-title":"Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations","volume":"2","author":"Altman","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib36","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1185\/03007990802434932","article-title":"The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate","volume":"24","author":"Hochberg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ard.2010.140848","article-title":"Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI","volume":"70","author":"Wildi","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.joca.2012.09.017","article-title":"Equivalence of a single dose (1200mg) compared to a three-time a day dose (400mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study","volume":"21","author":"Zegels","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1185\/03007995.2012.753430","article-title":"Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what\u05f3s the evidence?","volume":"29","author":"Hochberg","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2014-206792","article-title":"Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib","volume":"75","author":"Hochberg","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib43","first-page":"2423","article-title":"Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee","volume":"26","author":"Houpt","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","article-title":"Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens","volume":"74","author":"Fransen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2013-203906","article-title":"First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort","volume":"74","author":"Martel-Pelletier","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib46","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0363546514533777","article-title":"Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents","volume":"43","author":"Gallagher","year":"2015","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib47","unstructured":"Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Rockville MD; October 2011. \u3008http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0016485\/pdf\/TOC.pdf\u3009; [accessed 01.06.15]."},{"key":"10.1016\/j.semarthrit.2015.11.010_bib48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/bmj.38159.639028.7C","article-title":"Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials","volume":"329","author":"Lin","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib49","first-page":"2002","article-title":"Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial","volume":"31","author":"Tugwell","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.03.008","article-title":"Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis","volume":"143","author":"Simon","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib51","first-page":"CD007400","article-title":"Topical NSAIDs for chronic musculoskeletal pain in adults","volume":"9","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib52","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3899\/jrheum.130192","article-title":"A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel","volume":"40","author":"Rother","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib53","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/ket133","article-title":"A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis","volume":"52","author":"Conaghan","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib54","first-page":"4674","article-title":"Perkutane Therapie mit nicht-steroidalen Antiphlogistika","volume":"36","author":"Rechziegler","year":"1986","journal-title":"Therapiewoche"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib55","unstructured":"Walde HJ. Konzentration von Etofenamat in intra- und periartikul\u00e4ren Geweben nach perkutaner Applikation beim Menschen. Topische Behandlung mit nichtsteroidalen Antirheumatika. 4. Int. Etofenamat-Symposium vom 18.-21.6. 1987 in Stresa, Italien: pmi-Verlag Frankfurt\/Main, Der neue Weg; 1987. p. S91-4."},{"key":"10.1016\/j.semarthrit.2015.11.010_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00167-013-2408-0","article-title":"Penetration of topical diclofenac sodium 4% spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial","volume":"22","author":"Efe","year":"2014","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/bmj.39399.656331.25","article-title":"Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study","volume":"336","author":"Underwood","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib58","first-page":"4949","article-title":"Einsparung oraler Antirheumatika durch lokale Anwendung von Etofenamat Gel","volume":"30","author":"Blumberger","year":"1980","journal-title":"Therapiewoche"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib59","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ard.2003.020313","article-title":"Patient preference for placebo, acetaminophen (paracetamol) or celecoxib efficacy studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis","volume":"63","author":"Pincus","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"Suppl.","key":"10.1016\/j.semarthrit.2015.11.010_bib60","first-page":"43","article-title":"Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs","volume":"135","author":"Henry","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/ar146","article-title":"The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents","volume":"3","author":"Garcia Rodriguez","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1155\/2002\/516092","article-title":"Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents","volume":"16","author":"Hunt","year":"2002","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib63","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Masso Gonzalez","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib64","first-page":"1","article-title":"A double-blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis","volume":"12","author":"Chou","year":"2002","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib65","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF03261999","article-title":"Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)","volume":"35","author":"Castellsague","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib66","doi-asserted-by":"crossref","first-page":"78 S","DOI":"10.1016\/S0002-9343(99)00371-X","article-title":"Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events","volume":"107","author":"Freston","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02668031","article-title":"Clinical update of the relative safety of nabumetone in long-term clinical trials","volume":"3","author":"Lipani","year":"1995","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib68","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1572-0241.1998.00588.x","article-title":"A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Lanza","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00045391-200007020-00008","article-title":"Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System","volume":"7","author":"Singh","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib71","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib72","unstructured":"FDA. Information for healthcare professionals: Concomitant use of ibuprofen and aspirin. \u3008http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm125222.htm\u3009; 2006 [accessed 01.06.15]"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib73","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.112.112607","article-title":"Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study","volume":"126","author":"Olsen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib74","first-page":"CD005321","article-title":"Viscosupplementation for the treatment of osteoarthritis of the knee","volume":"2","author":"Bellamy","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib76","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.joca.2013.06.013","article-title":"Osteoarthritis pain mechanisms: basic studies in animal models","volume":"21","author":"Zhang","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semarthrit.2013.10.002","article-title":"Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis","volume":"43","author":"Bannuru","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/CMAMD.S12743","article-title":"US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials","volume":"6","author":"Miller","year":"2013","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib79","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","article-title":"Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis\u2014meta-analysis","volume":"19","author":"Bannuru","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib80","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/art.24925","article-title":"Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"61","author":"Bannuru","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib81","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/ard.2011.152017","article-title":"A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project","volume":"70","author":"Navarro-Sarabia","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.PHM.0000156899.18885.06","article-title":"Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience","volume":"84","author":"Petrella","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1248072","article-title":"Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee","volume":"19","author":"Waddell","year":"2006","journal-title":"J Knee Surg"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib84","first-page":"258","article-title":"Intrarticular hyaluronic acid in the treatment of arthroses","volume":"45","author":"Kausch","year":"2009","journal-title":"Orthop\u00e4dische Praxis"},{"issue":"Suppl. 1","key":"10.1016\/j.semarthrit.2015.11.010_bib85","first-page":"S910","article-title":"Do hyaluronic acid injections delay total knee replacement surgery?","volume":"65","author":"Abbott","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.18553\/jmcp.2007.13.2.113","article-title":"Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis","volume":"13","author":"Waddell","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib87","first-page":"6","article-title":"Cost-analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarthritis","volume":"57","author":"Mar","year":"2013","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib88","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/rheumatology\/41.11.1240","article-title":"Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study","volume":"41","author":"Karlsson","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.joca.2005.09.003","article-title":"A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee","volume":"14","author":"Kirchner","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib90","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/art.23026","article-title":"Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial","volume":"56","author":"Juni","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib91","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.joca.2011.07.016","article-title":"Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(R) vs hylan G-F20 [Synvisc(R)]) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study","volume":"19","author":"Pavelka","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib92","first-page":"527","article-title":"Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial","volume":"29","author":"Maheu","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib93","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/annrheumdis-2011-200972","article-title":"A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis","volume":"71","author":"Berenbaum","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib94","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.23103","article-title":"Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis","volume":"57","author":"Reichenbach","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib95","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2106\/00004623-200207000-00008","article-title":"Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases","volume":"84\u2013A","author":"Chen","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib96","first-page":"946","article-title":"Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee","volume":"33","author":"Bagga","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sarh.2002.33720","article-title":"Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?","volume":"32","author":"Ghosh","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00005742","article-title":"Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative","volume":"116","author":"Pozo","year":"1997","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00270463","article-title":"The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment","volume":"7","author":"Smith","year":"1987","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib100","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.orthres.2005.05.003.1100230619","article-title":"Apoptosis and nitric oxide in an experimental model of osteoarthritis in rabbit after hyaluronic acid treatment","volume":"23","author":"Diaz-Gallego","year":"2005","journal-title":"J Orthop Res"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib101","first-page":"297","article-title":"The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?","volume":"21","author":"Aviad","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib102","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","article-title":"The comparative safety of analgesics in older adults with arthritis","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3899\/jrheum.110307","article-title":"Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis","volume":"39","author":"Hochberg","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.joca.2013.02.007","article-title":"Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain","volume":"21","author":"Risser","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib105","first-page":"CD005522","article-title":"Tramadol for osteoarthritis","volume":"3","author":"Cepeda","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib106","first-page":"1358","article-title":"Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis","volume":"25","author":"Roth","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib107","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1185\/03007990903426787","article-title":"Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain","volume":"26","author":"Langley","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib109","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1185\/030079906X115595","article-title":"Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Gana","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib110","first-page":"594","article-title":"Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions","volume":"49","author":"Raber","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib111","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00044011-200525070-00002","article-title":"Tramadol SR formulations: pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)","volume":"25","author":"Cnota","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00044011-200525010-00003","article-title":"Effect of a simple dose-escalation schedule on tramadol tolerability: assessment in the clinical setting","volume":"25","author":"Tagarro","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.semarthrit.2015.11.010_bib113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40266-015-0243-3","article-title":"Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis","volume":"32","author":"Bruyere","year":"2015","journal-title":"Drugs Aging"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215002887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215002887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T03:47:56Z","timestamp":1653709676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215002887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0049017215002887"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.11.010","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis\u2014From evidence-based medicine to the real-life setting","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}